Question 1

What are the potential benefits and risks of combining fresolimumab with radiation therapy?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fresolimumab and Radiotherapy in Metastatic Breast Cancer clinical trial (NCT01401062). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fresolimumab and Radiotherapy in Metastatic Breast Cancer clinical trial (NCT01401062). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this combination treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fresolimumab and Radiotherapy in Metastatic Breast Cancer clinical trial (NCT01401062). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fresolimumab and Radiotherapy in Metastatic Breast Cancer clinical trial (NCT01401062). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer does not respond to this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fresolimumab and Radiotherapy in Metastatic Breast Cancer clinical trial (NCT01401062). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific eligibility criteria I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Fresolimumab and Radiotherapy in Metastatic Breast Cancer clinical trial (NCT01401062). Contact the study team or your healthcare provider for specific answers.

What this study is about